Clinical Trials Directory

Trials / Completed

CompletedNCT05655416

Treatment of Great Saphenous Vein Varicosities

Endovenous Chemical Ablation and Trendlenburg Operation for the Treatment of Great Saphenous Vein Varicosities

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Venous insufficiency at lower extremities may result in clinical problems from cosmetic issues to ulcerations. When the frequency of venous insufficiency and its related problems are considered besides their diversity, it is encountered as a public health issue. This pathology is reported to affect 40% of women and 20% of men.1 Patients with varicose veins may complain of unsightly appearance, aching, heaviness, pruritus, and early fatigue of the affected leg. These symptoms worsen with prolonged standing and sitting and are relieved by elevation of the leg above the level of the heart. Also, mild edema is often present. More severe signs include thrombophlebitis, hyperpigmentation, lipodermatosclerosis, ulceration, and bleeding

Conditions

Interventions

TypeNameDescription
PROCEDUREEndovenous chemical ablation with Trendelenburg's operation (eCAT)Endovenous chemical ablation with trendelenburg's operation (e CAT) is a method for the treatment of varicose veins

Timeline

Start date
2014-04-01
Primary completion
2021-04-01
Completion
2021-04-05
First posted
2022-12-19
Last updated
2022-12-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05655416. Inclusion in this directory is not an endorsement.